SanofiSNYNF
13F holders, Q1 2025 (March 31)2holders −1
0new positions
1sold out
$110.25avg. 13F price*
At the end of Q1 2025, 2 institutions reported holding Sanofi (SNYNF) in their 13F filings, down 1 from Q4 2024. 0 opened new positions and 1 sold out. The largest holders were Generali Investments CEE, investicni spolecnost, a.s. ($3.3M) and GAMMA Investing LLC ($30K).
- Company
- Sanofi
- CUSIP
- F5548N101
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q4 2024 → Q1 2025
| Institutions | Total Value | |
|---|---|---|
| New Positions | 0 | $0 |
| Exits | 1 | $14K |
All 13F filers, Q4 2024 → Q1 2025: 1,440 shares sold, net −1,440 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 2 holders
| Generali Investments CEE, investicni spolecnost, a.s. | 0.31% | Reduce -4.1% | 30,383 | $3.3M |
| GAMMA Investing LLC | 0.00% | No change | 270 | $30K |
"% of holder's portfolio" is SNYNF's weight in each manager's 13F, not the share of Sanofi the manager owns.